Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00339625 · ClinicalTrials.gov registry record · Phase 3

Polyp Prevention Trial

A Phase 3 study of Diet and Adenoma, sponsored by National Cancer Institute (NCI).

Completed
Registry status
Phase 3
Development phase
2,079
Enrollment target
1
Study location

NCT00339625: Completed Phase 3 study of Diet and Adenoma, sponsored by National Cancer Institute (NCI).

NCT00339625 is a Phase 3 study of Diet and Adenoma that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 2,079 participants, above the 314-participant average among 17 other Diet trials with a reported enrollment target (562% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00339625, a Phase 3 study of Diet and Adenoma, has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
Phase 3
Development phase
2,079 participants
Enrollment target
1
Study location

Study Summary

The primary objective of the Poly Prevention Trial (PPT) is to determine whether a low fat, high fiber, high vegetable and fruit eating plan will decrease the recurrence of adenomatous polyps of the large bowel. Secondary objectives of the PPT include 1) evaluating the effectiveness of the intervention program with respect to participant achievement of dietary goals; 2) examining the relation of dietary change and biochemical markers in blood; and 3) assessing the impact of the intervention on quality of life indicators.

Primary Outcome

Adenoma recurrence

Conditions Studied

Interventions

  • OTHER low fat, high fiber, high fruit and vegetable eating plan

Study Locations (1)

Maryland

  • National Cancer Institute (NCI), 9000 Rockville Pike - Bethesda

Trial Details

FieldValue
Enrollment Target 2,079 participants
Start Date 1991-06-19
Est. Completion 2020-05-11
Phase Phase 3
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT00339625 record still lists

NCT00339625 is an interventional study that assigns participants to a tested intervention. Its 2,079 participants enrollment target places it among the larger protocols in the corpus, above the 314-participant average among 17 other Diet trials with a reported enrollment target (562% higher).

The record links to 3 conditions, with Diet appearing as the primary indexed condition, and to 1 intervention - of which low fat, high fiber, high fruit and vegetable eating plan is the first listed.

NCT00339625 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00339625 about?

NCT00339625 is a clinical study titled "Polyp Prevention Trial". The primary objective of the Poly Prevention Trial (PPT) is to determine whether a low fat, high fiber, high vegetable and fruit eating plan will decrease the recurrence of adenomatous polyps of the large bowel. Secondary objectives of the PPT include 1) evaluating the effectiveness of the intervent...

What is the current status of trial NCT00339625?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,079 participants. The study started on 1991-06-19. Estimated completion is 2020-05-11.

What conditions does trial NCT00339625 study?

This clinical trial studies the following conditions: Diet, Adenoma, Polyps.

What interventions are being tested in trial NCT00339625?

The interventions under investigation include: low fat, high fiber, high fruit and vegetable eating plan (OTHER).

Who is sponsoring clinical trial NCT00339625?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00339625 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diet

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00339625's enrollment target sits among peer trials

2,079 2nd of 17 the highest of 17 other Diet trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diet trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04373564 · 2,076 participants · Phase 4

    Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

  • NCT00588068 · 2,070 participants

    Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

  • NCT06666192 · 2,067 participants · NA

    The Ohio State University (OSU) SCREEN Community Program

  • NCT07168993 · 2,063 participants · NA

    Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00339625, the US trial registry maintained by the National Library of Medicine. NCT00339625 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.